Bridgeway Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Bridgeway Capital Management's BMY Position: Q3 2026 in Review
Bridgeway Capital Management reduced its Bristol-Myers Squibb (BMY) stake by 30% in Q3 2026, selling an estimated $758K and leaving 28,500 shares worth $1.78M. The position accounts for 0.03% of the portfolio, ranked #572.
Bridgeway Capital Management first reported a position in BMY in Q1 2016 and has held it in 21 quarters since. The position peaked at $25.2M in Q3 2020. 2,561 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Bridgeway Capital Management held 28,500 shares of Bristol-Myers Squibb worth $1.78M as of Q3 2026.
- Bridgeway Capital Management sold 12,000 Bristol-Myers Squibb shares in Q3 2026, an estimated $758K.
- Bristol-Myers Squibb made up 0.03% of Bridgeway Capital Management's portfolio in Q3 2026, its #572 holding.
- Bridgeway Capital Management first reported a position in Bristol-Myers Squibb in Q1 2016 and has held it in 21 quarters since.
- Bridgeway Capital Management's Bristol-Myers Squibb position peaked at $25.2M in Q3 2020.
- 2,561 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Bridgeway Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.